Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1979 2
1980 15
1981 17
1982 16
1983 47
1984 45
1985 80
1986 77
1987 127
1988 83
1989 133
1990 97
1991 142
1992 98
1993 70
1994 87
1995 80
1996 68
1997 73
1998 58
1999 43
2000 42
2001 41
2002 34
2003 39
2004 42
2005 36
2006 36
2007 35
2008 26
2009 20
2010 25
2011 22
2012 22
2013 27
2014 32
2015 21
2016 34
2017 25
2018 32
2019 22
2020 41
2021 38
2022 33
2023 22
2024 24
2025 38
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,206 results

Results by year

Filters applied: . Clear all
Page 1
Sucralfate.
Rafiq N. Rafiq N. J Pak Med Assoc. 1992 May;42(5):105-7. J Pak Med Assoc. 1992. PMID: 1507384 No abstract available.
Sucralfate.
McCarthy DM. McCarthy DM. N Engl J Med. 1991 Oct 3;325(14):1017-25. doi: 10.1056/NEJM199110033251407. N Engl J Med. 1991. PMID: 1886624 Review. No abstract available.
Sucralfate-warfarin interaction.
Parrish RH, Waller B, Gondalia BG. Parrish RH, et al. Ann Pharmacother. 1992 Jul-Aug;26(7-8):1015-6. doi: 10.1177/106002809202600733. Ann Pharmacother. 1992. PMID: 1504385 No abstract available.
Sucralfate.
Jungnickel PW, Cantral KA. Jungnickel PW, et al. N Engl J Med. 1992 Mar 19;326(12):836. doi: 10.1056/NEJM199203193261214. N Engl J Med. 1992. PMID: 1538732 No abstract available.
Sucralfate and Helicobacter pylori.
Terano A, Shimada T, Hiraishi H. Terano A, et al. J Gastroenterol. 1996 Nov;31 Suppl 9:63-5. J Gastroenterol. 1996. PMID: 8959523 Review.
Sucralfate enhances the eradication rate of Helicobacter pylori when administered with antibiotics. Sucralfate acts on H. pylori through mucus gel. Whether sucralfate exerts its anti-ulcer action through the eradication of H. pylori is still controversial. .. …
Sucralfate enhances the eradication rate of Helicobacter pylori when administered with antibiotics. Sucralfate acts on H. pylo …
Sucralfate--safety and side effects.
Marks IN. Marks IN. Scand J Gastroenterol Suppl. 1991;185:36-42. Scand J Gastroenterol Suppl. 1991. PMID: 1957123 Review.
The clinical relevance of possible intraluminal binding and drug-drug interactions in patients receiving sucralfate therapy is also considered. Evidence is presented to show that sucralfate reduces the hyperphosphataemia in chronic uraemia, albeit at the risk of rai …
The clinical relevance of possible intraluminal binding and drug-drug interactions in patients receiving sucralfate therapy is also c …
Why do ulcers heal with sucralfate?
Lam SK. Lam SK. Scand J Gastroenterol Suppl. 1990;173:6-16. doi: 10.3109/00365529009091918. Scand J Gastroenterol Suppl. 1990. PMID: 2190306 Review.
It is concluded that sucralfate healing involves cytoprotective mechanisms and that these cannot be ignored in the planning of any anti-ulcer therapy. ...This review examines this question, using sucralfate as a model....
It is concluded that sucralfate healing involves cytoprotective mechanisms and that these cannot be ignored in the planning of any an …
[Sucralfate].
Hiraishi H, Kanke K, Terano A. Hiraishi H, et al. Nihon Rinsho. 2002 Feb;60 Suppl 2:688-92. Nihon Rinsho. 2002. PMID: 11979871 Review. Japanese. No abstract available.
Topical sucralfate for treatment of mucocutaneous conditions: A systematic review on clinical evidences.
Abtahi-Naeini B, Saffaei A, Sabzghabaee AM, Amiri R, Hosseini NS, Niknami E, Dehghani S. Abtahi-Naeini B, et al. Dermatol Ther. 2022 Apr;35(4):e15334. doi: 10.1111/dth.15334. Epub 2022 Feb 7. Dermatol Ther. 2022. PMID: 35080090
Sucralfate is an aluminum salt of sucrose octasulfate, generally considered safe in terms of adverse effects. Systemic sucralfate is FDA-approved for the treatment of duodenal ulcers. Since 1991, topical sucralfate has been used in various mucocutaneous condi …
Sucralfate is an aluminum salt of sucrose octasulfate, generally considered safe in terms of adverse effects. Systemic sucralfate …
Sucralfate--alternative therapy for peptic-ulcer disease.
Garnett WR. Garnett WR. Clin Pharm. 1982 Jul-Aug;1(4):307-14. Clin Pharm. 1982. PMID: 6764389 Review.
Approximately 3-5% of an orally administered dose of sucralfate is absorbed; more than 90% of the dose is excreted unchanged in the feces. Sucralfate remains at the site of gastric ulcers for up to six hours. ...Sucralfate is FDA-approved for short-term (up t …
Approximately 3-5% of an orally administered dose of sucralfate is absorbed; more than 90% of the dose is excreted unchanged in the f …
2,206 results